Bridges Investment Management Inc Abbott Laboratories Transaction History

Bridges Investment Management Inc

  • $6.51 Billion
  • Q2 2024

A detailed history of Bridges Investment Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Bridges Investment Management Inc holds 252,646 shares of ABT stock, worth $29.4 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
252,646
Previous 92,526 173.05%
Holding current value
$29.4 Million
Previous $10.5 Million 149.64%
% of portfolio
0.4%
Previous 0.34%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$100.73 - $112.44 $16.1 Million - $18 Million
160,120 Added 173.05%
252,646 $26.3 Million
Q1 2024

Apr 25, 2024
BUY
$109.52 - $120.96 $96,487 - $106,565
881 Added 0.96%
92,526 $10.5 Million
Q4 2023

Jan 23, 2024
BUY
$90.19 - $110.4 $918,404 - $1.12 Million
10,183 Added 12.5%
91,645 $10.1 Million
Q3 2023

Oct 24, 2023
SELL
$95.53 - $114.62 $32,384 - $38,856
-339 Reduced 0.41%
81,462 $7.89 Million
Q2 2023

Jul 07, 2023
SELL
$100.78 - $112.29 $455,424 - $507,438
-4,519 Reduced 5.24%
81,801 $8.92 Million
Q1 2023

Apr 28, 2023
BUY
$96.86 - $114.01 $14,625 - $17,215
151 Added 0.18%
86,320 $8.74 Million
Q4 2022

Feb 13, 2023
BUY
$95.06 - $111.52 $333,090 - $390,766
3,504 Added 4.24%
86,169 $9.46 Million
Q3 2022

Oct 21, 2022
SELL
$96.76 - $112.03 $104,017 - $120,432
-1,075 Reduced 1.28%
82,665 $8 Million
Q2 2022

Jul 12, 2022
BUY
$102.07 - $123.37 $465,030 - $562,073
4,556 Added 5.75%
83,740 $9.1 Million
Q1 2022

Apr 08, 2022
BUY
$114.02 - $139.04 $656,755 - $800,870
5,760 Added 7.84%
79,184 $9.37 Million
Q4 2021

Feb 01, 2022
SELL
$115.53 - $141.46 $4.3 Million - $5.26 Million
-37,200 Reduced 33.63%
73,424 $10.3 Million
Q3 2021

Nov 12, 2021
SELL
$116.66 - $129.06 $254,202 - $281,221
-2,179 Reduced 1.93%
110,624 $13.1 Million
Q2 2021

Jul 19, 2021
SELL
$105.79 - $124.53 $136,469 - $160,643
-1,290 Reduced 1.13%
112,803 $13.1 Million
Q1 2021

May 05, 2021
SELL
$108.84 - $128.23 $519,057 - $611,528
-4,769 Reduced 4.01%
114,093 $13.7 Million
Q4 2020

Feb 12, 2021
SELL
$105.0 - $114.42 $817,425 - $890,759
-7,785 Reduced 6.15%
118,862 $13 Million
Q3 2020

Nov 12, 2020
SELL
$91.64 - $111.29 $57,275 - $69,556
-625 Reduced 0.49%
126,647 $13.8 Million
Q2 2020

Aug 10, 2020
SELL
$76.57 - $98.0 $231,624 - $296,450
-3,025 Reduced 2.32%
127,272 $11.6 Million
Q1 2020

May 12, 2020
SELL
$62.82 - $91.86 $158,871 - $232,313
-2,529 Reduced 1.9%
130,297 $10.3 Million
Q4 2019

Feb 18, 2020
BUY
$78.51 - $87.4 $272,979 - $303,889
3,477 Added 2.69%
132,826 $11.5 Million
Q3 2019

Nov 12, 2019
SELL
$81.84 - $88.74 $475,490 - $515,579
-5,810 Reduced 4.3%
129,349 $10.8 Million
Q2 2019

Aug 07, 2019
SELL
$72.88 - $85.0 $337,070 - $393,125
-4,625 Reduced 3.31%
135,159 $11.4 Million
Q1 2019

May 01, 2019
SELL
$66.22 - $80.06 $382,221 - $462,106
-5,772 Reduced 3.97%
139,784 $11.2 Million
Q4 2018

Feb 11, 2019
BUY
$65.56 - $74.27 $226,837 - $256,974
3,460 Added 2.43%
145,556 $10.5 Million
Q3 2018

Nov 15, 2018
SELL
$60.81 - $73.36 $29,857 - $36,019
-491 Reduced 0.34%
142,096 $10.4 Million
Q2 2018

Aug 15, 2018
BUY
$57.57 - $63.54 $42,313 - $46,701
735 Added 0.52%
142,587 $8.7 Million
Q1 2018

Apr 25, 2018
BUY
$56.27 - $63.62 $4.4 Million - $4.97 Million
78,157 Added 122.71%
141,852 $8.5 Million
Q4 2017

Feb 09, 2018
BUY
$53.68 - $57.47 $111,922 - $119,824
2,085 Added 3.38%
63,695 $3.64 Million
Q3 2017

Oct 05, 2017
BUY
$48.06 - $53.64 $1.05 Million - $1.17 Million
21,800 Added 54.76%
61,610 $3.29 Million
Q3 2017

Oct 02, 2017
BUY
$48.06 - $53.64 $1.91 Million - $2.14 Million
39,810
39,810 $2.12 Million

Others Institutions Holding ABT

# of Institutions
3,133
Shares Held
1.33B
Call Options Held
8.63M
Put Options Held
7.17M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $204B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Bridges Investment Management Inc Portfolio

Follow Bridges Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridges Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bridges Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email